151 related articles for article (PubMed ID: 10721797)
1. Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits.
El-Shafy MA; Kellaway IW; Taylor G; Dickinson PA
J Drug Target; 2000; 7(5):355-61. PubMed ID: 10721797
[TBL] [Abstract][Full Text] [Related]
2. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
3. Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.
Miyamoto M; Natsume H; Satoh I; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 2001 Sep; 226(1-2):127-38. PubMed ID: 11532576
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
[TBL] [Abstract][Full Text] [Related]
5. The enhancing effect of nasal absorption of FITC-dextran 4,400 by beta-sitosterol beta-D-glucoside in rabbits.
Nakamura K; Maitani Y; Takayama K
J Control Release; 2002 Feb; 79(1-3):147-55. PubMed ID: 11853926
[TBL] [Abstract][Full Text] [Related]
6. DNA-crosslinked alginate and layered microspheres to modulate the release of encapsulated FITC-dextran.
Turner D; Baldwin E; Russell K; Wells LA
Eur J Pharm Biopharm; 2021 Jan; 158():313-322. PubMed ID: 33259898
[TBL] [Abstract][Full Text] [Related]
7. Nasal delivery of levonorgestrel for contraception: an experimental study in rats.
Shahiwala A; Misra A
Fertil Steril; 2004 Mar; 81 Suppl 1():893-8. PubMed ID: 15019826
[TBL] [Abstract][Full Text] [Related]
8. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
Pirouzmand H; Khameneh B; Tafaghodi M
Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
[TBL] [Abstract][Full Text] [Related]
9. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
[TBL] [Abstract][Full Text] [Related]
10. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro evaluation of thiolated chitosan microparticles.
Maculotti K; Genta I; Perugini P; Imam M; Bernkop-Schnürch A; Pavanetto F
J Microencapsul; 2005 Aug; 22(5):459-70. PubMed ID: 16361190
[TBL] [Abstract][Full Text] [Related]
12. Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting.
Dufes C; Schätzlein AG; Tetley L; Gray AI; Watson DG; Olivier JC; Couet W; Uchegbu IF
Pharm Res; 2000 Oct; 17(10):1250-8. PubMed ID: 11145231
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits.
Ugwoke MI; Exaud S; Van Den Mooter G; Verbeke N; Kinget R
Eur J Pharm Sci; 1999 Dec; 9(2):213-9. PubMed ID: 10620734
[TBL] [Abstract][Full Text] [Related]
14. Efficient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes.
Matsuo H; Okamura T; Chen J; Takanaga H; Ohtani H; Kaneda Y; Naito M; Tsuruo T; Sawada Y
J Drug Target; 2000; 8(4):207-16. PubMed ID: 11144231
[TBL] [Abstract][Full Text] [Related]
15. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive chitosan microspheres of carvedilol for nasal administration.
Patil S; Babbar A; Mathur R; Mishra A; Sawant K
J Drug Target; 2010 May; 18(4):321-31. PubMed ID: 20199172
[TBL] [Abstract][Full Text] [Related]
17. The structural barrier of absorptive mucosae: site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits.
Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y; Yamashita S
Biopharm Drug Dispos; 1993 Nov; 14(8):685-95. PubMed ID: 7508274
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability enhancement of ondansetron after nasal administration of Caesalpinia pulcherrima-based microspheres.
Suryawanshi SR; Thakare NP; More DP; Thombre NA
Drug Deliv; 2015; 22(7):894-902. PubMed ID: 24279581
[TBL] [Abstract][Full Text] [Related]
19. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin.
Ito Y; Ise A; Sugioka N; Takada K
Drug Dev Ind Pharm; 2010 Jul; 36(7):845-51. PubMed ID: 20180657
[TBL] [Abstract][Full Text] [Related]
20. Small Intestinal Permeability and Gut-Transit Time Determined with Low and High Molecular Weight Fluorescein Isothiocyanate-Dextrans in C3H Mice.
Woting A; Blaut M
Nutrients; 2018 May; 10(6):. PubMed ID: 29843428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
